Results 101 to 110 of about 2,196,235 (269)

Notas sobre a versão em língua portuguesa da Escala de Bem-Estar Espiritual Notes on the Portuguese-language version of the Spiritual Well-Being Scale

open access: yesJornal Brasileiro de Psiquiatria, 2013
OBJETIVO: Testar a Escala de Bem-Estar Espiritual (EBE), a versão em português da Spiritual Well-Being Scale (SWB), em uma amostra de universitários matriculados em cursos de pós-graduação da área da saúde, avaliando suas qualidades psicométricas.
Edson Zangiacomi Martinez   +3 more
doaj  

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

open access: yesMolecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice   +16 more
wiley   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

The payoffs and tradeoffs of hygienic behavior: A large-scale field study on a local population of honey bees [PDF]

open access: gold, 2021
Rya Seltzer   +6 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy